Outcomes of a Game-based Educational Intervention: Healthy Kids
Launched by MARMARA UNIVERSITY · Apr 24, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Healthy Kids," is looking at a fun and interactive way to help children learn about healthy habits and reduce the risk of obesity. Researchers want to see if using games and role-playing can make it easier for kids to understand the importance of staying active and eating well. The trial is open to all children, regardless of gender, who are between 2 and 21 years old, as long as they don't have certain health issues, like developmental delays or metabolic disorders.
If your child participates in this study, they will engage in enjoyable activities designed to teach them about health in a playful manner. The trial is not yet recruiting participants, but it aims to include a diverse group of children. It's important to note that children whose parents or guardians choose not to participate will not be included in the study. Overall, this trial hopes to find new ways to support children's health through play and learning.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All participants who do not meet the criteria of whether or not they agree to participate in the study will be included in the study.
- Exclusion Criteria:
- • neurodevelopmental delays
- • metabolic disorders potentially leading to obesity
- • physical disabilities
- • those whose parents or guardians declined participation.
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Pendik, Turkey
Patients applied
Trial Officials
Arzu uzuner
Study Director
Marmara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported